Thyrocare Technologies Ltd

Thyrocare Technologies primarily operates in healthcare segment and is primarily involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.

  • Market Cap: 2,762 Cr.
  • Current Price: 521.10
  • 52 weeks High / Low 723.00 / 406.65
  • Book Value: 71.59
  • Stock P/E: 24.23
  • Dividend Yield: 3.84 %
  • ROCE: 31.25 %
  • ROE: 20.21 %
  • Sales Growth (3Yrs): 16.34 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 10.00
Edit ratios
Pros:
Company is virtually debt free.
Stock is providing a good dividend yield of 3.84%.
Company has been maintaining a healthy dividend payout of 93.98%
Cons:
Stock is trading at 7.28 times its book value

Peer comparison Sector: Healthcare // Industry: Healthcare

Loading peers table ...

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
82 82 78 90 89 96 88 97 100 108 98 94
46 48 44 55 50 55 54 63 56 57 55 64
Operating Profit 36 34 34 35 39 41 34 34 44 51 43 29
OPM % 44% 42% 43% 39% 44% 43% 39% 35% 44% 47% 43% 31%
Other Income 3 3 4 12 3 3 4 3 3 3 1 -42
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 3 3 3 3 3 4 4 4 4 5 5 6
Profit before tax 36 34 35 44 39 40 34 33 43 48 39 -18
Tax % 35% 31% 37% 36% 35% 34% 35% 37% 30% 23% 23% 1%
Net Profit 23 23 22 28 25 27 22 21 30 37 30 -18
EPS in Rs 4.31 4.36 4.08 5.15 4.72 4.94 4.25 3.92 5.70 7.22 5.66 -3.43
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
58 78 109 134 150 180 235 298 332 370 400
31 42 60 71 81 105 140 182 195 222 233
Operating Profit 28 36 49 64 69 75 95 115 137 148 167
OPM % 48% 46% 45% 47% 46% 41% 40% 39% 41% 40% 42%
Other Income 7 3 5 18 7 9 6 -16 24 14 -34
Interest 0 0 0 0 0 0 1 0 0 0 1
Depreciation 1 1 2 3 6 11 11 12 12 14 20
Profit before tax 33 38 52 78 69 73 89 87 148 147 112
Tax % 30% 34% 33% 27% 33% 33% 34% 46% 35% 35%
Net Profit 23 25 35 57 46 49 59 47 96 95 79
EPS in Rs 18.30 22.97 32.33 52.04 42.28 9.75 10.94 8.69 17.88 18.04 15.15
Dividend Payout % 88% 0% 0% 0% 0% 157% 91% 115% 56% 111%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:19.81%
3 Years:16.34%
TTM:8.03%
Compounded Profit Growth
10 Years:%
5 Years:14.79%
3 Years:16.44%
TTM:19.69%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:-10.04%
1 Year:9.94%
Return on Equity
10 Years:%
5 Years:18.94%
3 Years:19.15%
Last Year:20.21%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
11 11 11 11 11 51 54 54 54 53 53
Reserves 31 57 92 149 195 229 322 364 400 403 325
Borrowings 0 25 25 25 25 0 0 0 0 0 9
30 8 10 11 14 14 39 26 31 32 55
Total Liabilities 72 101 137 197 246 293 414 444 485 488 442
15 16 20 75 87 83 93 89 103 108 112
CWIP 0 0 0 10 6 6 1 2 0 1 4
Investments 0 24 24 77 119 162 266 299 315 289 239
57 61 93 34 33 42 55 54 68 89 88
Total Assets 72 101 137 197 246 293 414 444 485 488 442

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
32 31 37 46 46 36 67 89 112 96
11 -24 -18 -88 -52 -21 -19 -40 -48 -3
-38 25 0 1 0 -23 -45 -48 -65 -96
Net Cash Flow 5 32 19 -42 -6 -7 3 1 -1 -3

Ratios Standalone Figures in Rs. Crores / View Consolidated

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 55% 47% 50% 33% 27% 27% 29% 33% 31%
Debtor Days 11 14 11 9 12 9 11 7 10 11
Inventory Turnover 24.00 23.97 25.94 25.97 26.98 27.76 25.16 21.95 23.12